David Grayzel

Dave Grayzel is a partner in the life sciences group.   Dave joined Atlas in 2010 as managing director of Atlas Venture Development Corp (AVDC).  AVDC is an innovative, asset centric structure that partners with pharma and biotech companies to develop late preclinical and clinical stage programs through to key value inflection points.  AVDC has created Arteaus Therapeutics, Annovation Biopharma, and Ataxion.  Arteaus, which developed a CGRP antibody for migraine prevention, was acquired by Eli Lilly and Company.  Annovation is developing novel anesthesia therapies in partnership with The Medicines Company, and Ataxion is developing novel therapies for underserved neurological diseases in partnership with Biogen.

Prior to joining Atlas, Dave led Infinity Pharmaceutical’s (NASDAQ: INFI) clinical research efforts as the head of clinical development and medical affairs. Having joined Infinity as a startup, Dave established the clinical capabilities to run trials from Phase I through global Phase III registration studies.  His responsibilities included clinical strategy and development, operations, pharmacovigilance, and medical affairs.  He also co-chaired the scientific leadership team.  In addition, as a member of the executive leadership team, he was instrumental in the overall corporate and business strategy, which included establishing corporate alliances with Medimmune/AZ and Purdue Pharma, as well as executing Infinity’s IPO in 2006.  Prior to Infinity, Dave was director of corporate development and business operations at Dyax, a biopharma company focused on antibody and protein therapeutics.

He received an MD from Harvard Medical School and completed his internship and residency training in internal medicine at Massachusetts General Hospital. Prior to his medical training, he was a curriculum director at Stanford University Medical Center, where he created Stanford’s first case-based medical ethics curriculum.  He received a BA with honors from Stanford University.

Dave serves on the board of Acera: The Massachusetts School for Science, Creativity, and Leadership, which he and his wife Courtney started in 2009. Most of his free time is spent with his children, Annabelle and Benjamin, sledding, swimming, and rooting for the NY Giants (but not the Yankees).